Sperm Count Test Market is Estimated To Witness High Growth Owing To Rising Male Infertility
 |
| Sperm Count Test Market |
Market Overview:
The global Sperm Count Test Market is estimated to be valued at US$ 517.5 Mn in 2022 and is expected to exhibit a CAGR of 12.5% over the forecast period 2023-2030. Sperm count test kits help measure the concentration of sperm in a man's semen. It provides an overall assessment of fertility potential and detection of problems that may be impairing fertility. The convenience of home-based sperm count testing kits along with accuracy is driving the market growth.
Market key trends:
One of the key trends in the sperm count test market is the increasing preference for home-based testing kits. Conventional sperm count tests require visiting a fertility clinic or doctor which takes more time. The home-based kits allow testing the sperm sample conveniently at home and providing results privately. They are easy-to-use with simple instructions. The rise in male infertility globally and delay in childbearing has boosted the demand for home sperm testing kits for preliminary self-assessment of fertility. Their availability over-the-counter without prescription is a major factor propelling the sperm count test market.
Segment Analysis:
The global sperm count test market is segmented based on product, by application, end user, and geography. Based on product, the market is segmented into home & personal care kits, point-of-care kits, and others. Among these, the home & personal care kits segment is expected to dominate the market during the forecast period. This is attributed to their easy availability and convenience to use at home without visiting a clinic.
Key Takeaways:
The global Sperm Count Test Market Trend is expected to witness high growth, exhibiting a CAGR of 12.5% over the forecast period, due to increasing awareness about male fertility testing and rising cases of male infertility.
Regional Analysis:
North America is expected to dominate the global sperm count test market over the forecast period. This is attributed to the increasing male infertility rates, adoption of advanced diagnostic methods, and existence of well-established healthcare infrastructure in the region.
Key Players:
Key players operating in the sperm count test market are LLC Medical Group, Abbot Laboratories, CooperSurgical Inc., Hamilton Thorne Ltd., Medical Electronic Systems, Microptic S.L., ContraVac INC, MotilityCount Aps, DNA Diagnostics Center, Prestige Consumer Healthcare, Sandstone Diagnostics, bioMerieux SA, ASKA Pharmaceuticals, Clinical Genetics Pty Ltd, Halotech DNA, SAS MARKit, Trak Fertility, UEBE Medical GmbH, Vitrolife, and Welling Home Health.
Comments
Post a Comment